Ignite Creation Date:
2025-12-25 @ 3:26 AM
Ignite Modification Date:
2026-05-13 @ 2:17 PM
Study NCT ID:
NCT02085005
Status:
WITHDRAWN
Last Update Posted:
2014-11-18
First Post:
2014-03-10
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Capecitabine Plus Aflibercept as Maintenance Therapy Following Capecitabine Plus Oxaliplatin Plus Aflibercept in Patients With Metastatic Colorectal Cancer
Sponsor:
Sanofi
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
LPS13787
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |